Tong Tri C, Hernandez Mark, Richardson William H, Betten David P, Favata Michael, Riffenburgh Robert H, Clark Richard F, Tanen David A
University of California San Diego Medical Center, Division of Medical Toxicology, Department of Emergency Medicine, San Diego, CA 92103, USA.
Ann Emerg Med. 2007 Sep;50(3):282-8. doi: 10.1016/j.annemergmed.2006.12.015. Epub 2007 Jun 7.
The foraging of wild mushrooms can be complicated by toxicity from several mushroom types. Amatoxin, a peptide contained in several mushroom species, accounts for the majority of severe mushroom poisonings by binding to RNA polymerase II irreversibly, leading to severe hepatonecrosis. There is no effective antidote for severe amatoxin poisoning. We compare the effectiveness of 5 potential antidotal therapies in limiting the degree of hepatonecrosis in a randomized, controlled, murine model of amatoxin-induced hepatotoxicity.
One hundred eighty male Institute of Cancer Research mice were randomized into 6 equal groups. Within each group, 21 mice were intraperitoneally injected with 0.6 mg/kg of alpha-amanitin (amatoxin); the remaining 9 were injected with 0.9% normal saline solution. Four hours postinjection, each group of 30 mice was randomized to 1 of 5 intraperitoneal treatments (N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, or silybin) or normal saline solution. Repeated dosing was administered intraperitoneally every 4 to 6 hours for 48 hours. After 48 hours of treatment, each subject was killed, cardiac blood was aspirated for hepatic aminotransferase measurements (alanine transaminase and aspartate transaminase), and liver specimens were harvested to evaluate the extent of hepatonecrosis. The degree of hepatonecrosis was determined by a pathologist blinded to the treatment group and divided into 5 categories according to percentage of hepatonecrosis.
Amanitin significantly increased aspartate transaminase in treated mice compared with normal saline solution-treated controls (mean [SD] 2,441 [2,818] IU/L versus 310 [252]; P=.03). None of the antidotal therapies were found to significantly decrease the increase in aminotransferases compared with controls. Further, none of the antidotal therapies demonstrated an important decrease in hepatonecrosis compared with controls when a histologic grading scale was used.
In this murine model, N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid, and silybin were not effective in limiting hepatic injury after alpha-amanitin poisoning. Increases of aminotransferases and degrees of histologic hepatonecrosis were not attenuated by these antidotal therapies.
野生蘑菇的采食可能因几种蘑菇的毒性而变得复杂。鹅膏毒素是几种蘑菇中含有的一种肽,它通过不可逆地结合RNA聚合酶II导致大多数严重的蘑菇中毒,进而引发严重的肝坏死。对于严重的鹅膏毒素中毒,目前尚无有效的解毒剂。我们在一个随机对照的小鼠模型中,比较了5种潜在解毒疗法在限制鹅膏毒素诱导的肝毒性所致肝坏死程度方面的有效性。
180只雄性癌症研究所小鼠被随机分为6个相等的组。每组中,21只小鼠腹腔注射0.6mg/kg的α-鹅膏菌素(鹅膏毒素);其余9只注射0.9%的生理盐水溶液。注射后4小时,每组30只小鼠被随机分配接受5种腹腔治疗(N-乙酰半胱氨酸、苄青霉素、西咪替丁、硫辛酸或水飞蓟宾)中的一种或生理盐水溶液。每4至6小时腹腔重复给药一次,持续48小时。治疗48小时后,处死每只动物,抽取心脏血液进行肝转氨酶测量(丙氨酸转氨酶和天冬氨酸转氨酶),并采集肝脏标本以评估肝坏死程度。肝坏死程度由对治疗组不知情的病理学家确定,并根据肝坏死百分比分为5类。
与生理盐水处理的对照组相比,鹅膏毒素显著增加了处理小鼠中天冬氨酸转氨酶的水平(平均值[标准差]为2441[2818]IU/L,而对照组为310[252];P = 0.03)。与对照组相比未发现任何解毒疗法能显著降低转氨酶的升高。此外,当使用组织学分级量表时,与对照组相比,没有一种解毒疗法能显著减少肝坏死。
在这个小鼠模型中,N-乙酰半胱氨酸、苄青霉素、西咪替丁、硫辛酸和水飞蓟宾在限制α-鹅膏毒素中毒后的肝损伤方面无效。这些解毒疗法并未减轻转氨酶的升高和组织学肝坏死程度。